Results 1 to 10 of about 464 (69)

The Next Generation Fecal Microbiota Transplantation: To Transplant Bacteria or Virome

open access: yesAdvanced Science, 2023
Fecal microbiota transplantation (FMT) has emerged as a promising therapeutic approach for dysbiosis‐related diseases. However, the clinical practice of crude fecal transplants presents limitations in terms of acceptability and reproductivity ...
You Yu, Weihong Wang, Faming Zhang
doaj   +2 more sources

Fecal microbiota transplantation for induction of remission, maintenance and rescue in patients with corticosteroid-dependent ulcerative colitis: a long-term follow-up real-world cohort study [PDF]

open access: yesIntestinal Research, 2022
Background/Aims To study role of fecal microbiota transplantation (FMT) in induction, maintenance, and rescue in patients with corticosteroid-dependent ulcerative colitis (CDUC).
Avnish Kumar Seth, Priti Jain
doaj   +1 more source

Fecal Microbiota Transplant: Could it be an Effective Choice in ‎Irritable Bowel Syndrome?‎ ‎ [PDF]

open access: yesAfro-Egyptian Journal of Infectious and Endemic Diseases, 2022
Irritable Bowel Syndrome (IBS) is a common problem facing gastroenterologists and primary care physicians, its prevalence ranged between 10 to 20 % of the population worldwide .
Hala Hussien
doaj   +1 more source

Does Fecal Microbiota Transplant Have a Role in Treating Recurrent Clostridioides difficile Infection in Rural Hospitals?

open access: yesFrontiers in Public Health, 2021
Clostridioides difficile infection possesses a significant economical burden, specifically in the inpatient and rural settings. Fecal Microbiota Transplant has been used for treatment of recurrent Clostridioides difficile but its utility is limited by ...
Krishna Vedala   +3 more
doaj   +1 more source

Fecal Microbiota Transplantation in Decompensated Cirrhosis: A Systematic Review on Safety and Efficacy

open access: yesAntibiotics, 2022
Background and Aims: Due to increasing knowledge of the “gut–liver axis”, there has been growing interest regarding the use of fecal microbiota transplant in the management of chronic liver disease. There are limited data available and current guidelines
Annie S. Hong   +4 more
doaj   +1 more source

The Role of Fecal Microbiota Transplantation in the Allogeneic Stem Cell Transplant Setting

open access: yesMicroorganisms, 2023
Microbiota changes during allogeneic hematopoietic stem cell transplantation has several known causes: conditioning chemotherapy and radiation, broad-spectrum antibiotic administration, modification in nutrition status and diet, and graft-versus-host ...
Elisabetta Metafuni   +9 more
doaj   +1 more source

What Makes a Successful Donor? Fecal Transplant from Anxious-Like Rats Does Not Prevent Spinal Cord Injury-Induced Dysbiosis

open access: yesBiology, 2021
Spinal cord injury (SCI) causes gut dysbiosis and an increased prevalence of depression and anxiety. Previous research showed a link between these two consequences of SCI by using a fecal transplant from healthy rats which prevented both SCI-induced ...
Emma K. A. Schmidt   +5 more
doaj   +1 more source

Profiling Living Bacteria Informs Preparation of Fecal Microbiota Transplantations. [PDF]

open access: yesPLoS ONE, 2017
Fecal microbiota transplantation is a compelling treatment for recurrent Clostridium difficile infections, with potential applications against other diseases associated with changes in gut microbiota.
Nathaniel D Chu   +4 more
doaj   +1 more source

Recent advances in the treatment of functional dyspepsia and irritable bowel syndrome

open access: yesJournal of Education, Health and Sport, 2023
Introduction and purpose: While irritable bowel syndrome (IBS) and functional dyspepsia (FD) are common problems in everyday clinical practice, their treatment often remains inefficient.
Jan Bieniasz   +5 more
doaj   +1 more source

High Throughput Analysis Reveals Changes in Gut Microbiota and Specific Fecal Metabolomic Signature in Hematopoietic Stem Cell Transplant Patients

open access: yesMicroorganisms, 2021
There is mounting evidence for the emerging role of gut microbiota (GM) and its metabolites in profoundly impacting allogenic hematopoietic stem cell transplantation (allo-HSCT) and its subsequent complications, mainly infections and graft versus host ...
Soumaya Kouidhi   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy